NM_000162.5:c.1120G>C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000162.5(GCK):c.1120G>C(p.Val374Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000162.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152272Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74388
ClinVar
Submissions by phenotype
not provided Pathogenic:1
DNA sequence analysis of the GCK gene demonstrated a sequence change, c.1120G>C, in exon 9 that results in an amino acid change, p.Val374Leu. The p.Val374Leu change affects a highly conserved amino acid residue located in a domain of the GCK protein that is not known to be functional. The p.Val374Leu substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, Align GVGD, REVEL). This particular amino acid change does not appear to have been described in the literature in other individuals with GCK related disorders. However, different sequence changes affecting the same amino acid residues (p.Val374Glu and p.Val374Met) have been described in multiple families with MODY (PMID: 19790256). This sequence change has not been described in the population databases such as ExAC and gnomAD. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at